10X Capital Venture Acquisition Corp. III - Quarter Report: 2022 September (Form 10-Q)
Table of Contents
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Cayman Islands |
98-1611637 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant |
VCXB.U |
New York Stock Exchange | ||
Class A ordinary shares, par value $0.0001 per share |
VCXB |
New York Stock Exchange | ||
Warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share |
VCXB WS |
New York Stock Exchange |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Table of Contents
10X CAPITAL VENTURE ACQUISITION CORP. III
QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2022
TABLE OF CONTENTS
Page | ||||||
PART 1-FINANCIAL INFORMATION | ||||||
Item 1. |
Condensed Financial Statements | |||||
Condensed Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021 | 1 | |||||
2 | ||||||
3 | ||||||
4 | ||||||
Notes to Unaudited Condensed Financial Statements | 5 | |||||
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations | 18 | ||||
Item 3. |
Quantitative and Qualitative Disclosures about Market Risk | 22 | ||||
Item 4. |
Control and Procedures | 23 | ||||
PART II-OTHER INFORMATION | ||||||
Item 1. |
Legal Proceedings | 23 | ||||
Item 1A. |
Risk Factors | 23 | ||||
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds | 23 | ||||
Item 3. |
Defaults Upon Senior Securities | 24 | ||||
Item 4. |
Mine Safety Disclosures | 24 | ||||
Item 5. |
Other Information | 24 | ||||
Item 6. |
Exhibits | 24 | ||||
25 |
Table of Contents
September 30, 2022 |
December 31, 2021 |
|||||||
(Unaudited) |
||||||||
Assets |
||||||||
Current assets: |
||||||||
Cash |
$ | 127,854 | $ | — | ||||
Prepaid expenses |
100,532 | 26,800 | ||||||
Total current assets |
228,386 | 26,800 | ||||||
Investments held in Trust Account |
306,355,099 | — | ||||||
Offering costs associated with initial public offering |
— | 540,102 | ||||||
Total Assets |
$ |
306,583,485 |
$ |
566,902 |
||||
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 223,456 | $ | 215,247 | ||||
Accrued expenses |
158,279 | 236,491 | ||||||
Note payable - related party |
— | 134,771 | ||||||
Total current liabilities |
381,735 | 586,509 | ||||||
Deferred underwriting commissions |
14,280,000 | — | ||||||
Total Liabilities |
14,661,735 | 586,509 | ||||||
Commitments and Contingencies |
||||||||
Class A ordinary shares subject to possible redemption; 30,000,000 and -0- |
306,255,099 | — | ||||||
Shareholders’ Deficit |
||||||||
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding |
— | — | ||||||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 1,153,000 and -0- non-redeemable shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively |
115 | — | ||||||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 10,000,000 and 10,005,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021 |
1,000 | 1,001 | (1) | |||||
Additional paid-in capital |
— | 23,999 | ||||||
Accumulated deficit |
(14,334,464 | ) | (44,607 | ) | ||||
Total Shareholders’ Deficit |
(14,333,349 | ) | (19,607 | ) | ||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
$ |
306,583,485 |
$ |
566,902 |
||||
(1) | This number includes up to 1,305,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter. On January 14, 2022, the underwriter partially exercised the over-allotment option to purchase additional 3,900,000 Units; thus, 5,000 Class B ordinary shares were subsequently forfeited when the over-allotment option expired on February 25, 2022. Shares and associated amounts have been retroactively restated to reflect the share capitalization of 421,667 Class B ordinary shares outstanding (see Note 5). |
For the nine |
For the period from February 10, 2021 (inception) |
|||||||||||||||
For the three months ended September 30, |
months ended September 30, |
through September 30, |
||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
General and administrative expenses |
$ | 223,782 | $ | 12,784 | $ | 865,593 | $ | 23,717 | ||||||||
Administrative expenses - related party |
112,500 | — | 337,500 | — | ||||||||||||
Loss from operations |
(336,282 | ) | (12,784 | ) | (1,203,093 | ) | (23,717 | ) | ||||||||
Other income: |
||||||||||||||||
Income from investments held in Trust Account |
1,448,249 | — | 1,855,099 | — | ||||||||||||
Total other income |
1,448,249 | — | 1,855,099 | — | ||||||||||||
Net income (loss) |
$ | 1,111,967 | $ | (12,784 | ) | $ | 652,006 | $ | (23,717 | ) | ||||||
Weighted average Class A ordinary shares - basic and diluted |
31,153,000 | — | 29,669,524 | — | ||||||||||||
Basic and diluted net income per share, Class A ordinary shares |
$ | 0.03 | $ | — | $ | 0.02 | $ | — | ||||||||
Weighted average Class B ordinary shares - basic |
10,000,000 | 8,700,000 | (1) |
9,938,095 | 8,700,000 | (1) | ||||||||||
Weighted average Class B ordinary shares - diluted |
10,000,000 | 8,700,000 | (1) |
10,000,000 | 8,700,000 | (1) | ||||||||||
Basic and diluted net income (loss) per share, Class B ordinary shares |
$ | 0.03 | $ | (0.00 | ) | $ | 0.02 | $ | (0.00 | ) | ||||||
(1) | This number excludes up to 1,305,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter. On January 14, 2022, the underwriter partially exercised the over-allotment option to purchase additional 3,900,000 Units; thus, 5,000 Class B ordinary shares were subsequently forfeited when the over-allotment option expired on February 25, 2022. Shares and associated amounts have been retroactively restated to reflect the surrender of 2,089,167 Class B ordinary shares for no consideration, and the share capitalization of 421,667 Class B ordinary shares outstanding (see Note 5). |
Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
|||||||||||||||||||||||||
Non-redeemable Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance - December 31, 2021 |
— |
$ |
— |
10,005,000 |
$ |
1,001 |
$ |
23,999 |
$ |
(44,607 |
) |
$ |
(19,607 |
) | ||||||||||||||
Sale of private placement units in private placement |
1,153,000 | 115 | — | — | 11,529,885 | — | 11,530,000 | |||||||||||||||||||||
Fair value of warrants included in the Units sold in the Initial Public Offering |
— | — | — | — | 12,300,000 | — | 12,300,000 | |||||||||||||||||||||
Offering costs associated with issuance of warrants as part of the Units in the Initial Public Offering |
— | — | — | — | (829,867 | ) | — | (829,867 | ) | |||||||||||||||||||
Forfeiture of Class B ordinary shares |
— | — | (5,000 | ) | (1 | ) | 1 | — | — | |||||||||||||||||||
Accretion for Class A ordinary shares to redemption amount |
— | — | — | — | (23,024,018 | ) | (13,186,764 | ) | (36,210,782 | ) | ||||||||||||||||||
Net loss |
— | — | — | — | — | (347,368 | ) | (347,368 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - March 31, 2022 (Unaudited) |
1,153,000 |
115 |
10,000,000 |
1,000 |
— |
(13,578,739 |
) |
(13,577,624 |
) | |||||||||||||||||||
Increase in redemption value of Class A ordinary shares subject to possible redemption |
— |
— |
— |
— |
— |
(306,850 | ) | (306,850 | ) | |||||||||||||||||||
Net loss |
— | — | — | — | — | (112,593 | ) | (112,593 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - June 30, 2022 (Unaudited) |
1,153,000 |
115 |
10,000,000 |
1,000 |
— |
(13,998,182 |
) |
(13,997,067 |
) | |||||||||||||||||||
Increase in redemption value of Class A ordinary shares subject to possible redemption |
— |
— |
— |
— |
— |
(1,448,249 | ) | (1,448,249 | ) | |||||||||||||||||||
Net income |
— | — | — | — | — | 1,111,967 | 1,111,967 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - September 30, 2022 (Unaudited) |
1,153,000 |
$ |
115 |
10,000,000 |
$ |
1,000 |
$ |
— |
$ |
(14,334,464 |
) |
$ |
(14,333,349 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary Shares |
Additional Paid-in Capital |
Total Shareholders’ Equity |
||||||||||||||||||||||||||
Non-redeemable Class A |
Class B |
Accumulated Deficit |
||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance - February 10, 2021 (inception) |
— |
$ |
— |
— |
$ |
— |
$ |
— |
$ |
— |
$ |
— |
||||||||||||||||
Issuance of Class B ordinary shares to Sponsor (1) |
— |
— |
10,005,000 |
1,001 |
23,999 |
— |
25,000 |
|||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
(10,547 |
) |
(10,547 |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - March 31, 2021 (Unaudited) |
— |
— |
10,005,000 |
1,001 |
23,999 |
(10,547 |
) |
14,453 |
||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
(386 |
) |
(386 |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - June 30, 2021 (Unaudited) |
— |
— |
10,005,000 |
1,001 |
23,999 |
(10,933 |
) |
14,067 |
||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
(12,784 |
) |
(12,784 |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance - September 30, 2021 (Unaudited) |
— |
$ |
— |
10,005,000 |
$ |
1,001 |
$ |
23,999 |
$ |
(23,717 |
) |
$ |
1,283 |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | This number includes up to 1,305,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter. On January 14, 2022, the underwriter partially exercised the over-allotment option to purchase additional 3,900,000 Units; thus, 5,000 Class B ordinary shares were subsequently forfeited when the over-allotment option expired on February 25, 2022. Shares and associated amounts have been retroactively restated to reflect the surrender of 2,089,167 Class B ordinary shares for no consideration, and the share capitalization of 421,667 Class B ordinary shares outstanding (see Note 5). |
For the nine months ended September 30, 2022 |
For the period from February 10, 2021 (inception) through September 30, 2021 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income (loss) |
$ | 652,006 | $ | (23,717 | ) | |||
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
General and administrative expenses paid by related party in exchange for issuance of Class B ordinary shares |
— | 10,547 | ||||||
Income from investments held in Trust Account |
(1,855,099 | ) | — | |||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
(73,732 | ) | — | |||||
Accounts payable |
95,234 | 1,483 | ||||||
Accrued expenses |
130,642 | 11,687 | ||||||
|
|
|
|
|||||
Net cash used in operating activities |
(1,050,949 | ) | — | |||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Cash deposited in Trust Account |
(304,500,000 | ) | — | |||||
|
|
|
|
|||||
Net cash used in investing activities |
(304,500,000 | ) | — | |||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Repayment of note payable to related party |
(136,617 | ) | — | |||||
Proceeds received from initial public offering, gross |
300,000,000 | — | ||||||
Proceeds received from private placement |
11,530,000 | — | ||||||
Offering costs paid |
(5,714,580 | ) | — | |||||
|
|
|
|
|||||
Net cash provided by financing activities |
305,678,803 | — | ||||||
|
|
|
|
|||||
Net change in cash |
127,854 | — | ||||||
Cash - beginning of the period |
— | — | ||||||
|
|
|
|
|||||
Cash - end of the period |
$ |
127,854 |
$ |
— |
||||
|
|
|
|
|||||
Supplemental disclosure of noncash financing activities: |
||||||||
Offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares |
$ | — | $ | 14,453 | ||||
|
|
|
|
|||||
Offering costs included in accounts payable |
$ | (87,025 | ) | $ | 93,065 | |||
|
|
|
|
|||||
Offering costs included in accrued expenses |
$ | (208,854 | ) | $ | 128,179 | |||
|
|
|
|
|||||
Offering costs paid by related party under promissory note |
$ | 1,847 | $ | 52,245 | ||||
|
|
|
|
|||||
Deferred underwriting commissions |
$ | 14,280,000 | $ | — | ||||
|
|
|
|
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
For the three months ended September 30, |
||||||||||||
2022 |
2021 |
|||||||||||
Class A |
Class B |
Class B |
||||||||||
Basic and diluted net income (loss) per ordinary share: |
||||||||||||
Numerator: |
||||||||||||
Allocation of net income (loss) - basic |
$ |
841,764 |
$ |
270,203 |
$ |
(12,784 |
) | |||||
Allocation of net income (loss) - diluted |
$ | 841,764 | $ | 270,203 | $ | (12,784 | ) | |||||
Denominator: |
||||||||||||
Basic weighted average ordinary shares outstanding |
31,153,000 |
10,000,000 |
8,700,000 |
|||||||||
Diluted weighted average ordinary shares outstanding |
31,153,000 | 10,000,000 | 8,700,000 | |||||||||
Basic net income (loss) per ordinary share |
$ | 0.03 | $ | 0.03 | $ | (0.00 | ) | |||||
Diluted net income (loss) per ordinary share |
$ |
0.03 |
$ |
0.03 |
$ |
(0.00 |
) | |||||
For the nine months ended September 30, 2022 |
For the period from February 10, 2021 (inception) through September 30, 2021 |
|||||||||||
Class A |
Class B |
Class B |
||||||||||
Basic and diluted net income (loss) per ordinary share: |
||||||||||||
Numerator: |
||||||||||||
Allocation of net income (loss ) - basic |
$ | 488,409 | $ | 163,597 | $ | (23,717 | ) | |||||
Allocation of net income (loss) - diluted |
$ |
487,647 |
$ |
164,359 |
$ |
(23,717 |
) | |||||
Denominator: |
||||||||||||
Basic weighted average ordinary shares outstanding |
29,669,524 |
9,938,095 |
8,700,000 |
|||||||||
Diluted weighted average ordinary shares outstanding |
29,669,524 | 10,000,000 | 8,700,000 | |||||||||
Basic net income (loss) per ordinary share |
$ |
0.02 |
$ |
0.02 |
$ |
(0.00 |
) | |||||
Diluted net income (loss) per ordinary share |
$ | 0.02 | $ | 0.02 | $ | (0.00 | ) | |||||
Gross proceeds |
$ | 300,000,000 | ||
Less: |
||||
Proceeds allocated to Public Warrants |
(12,300,000 | ) | ||
Class A ordinary shares issuance costs |
(19,410,782 | ) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
36,210,782 | |||
Class A ordinary shares subject to possible redemption as of March 31, 2022 |
304,500,000 |
|||
Increase in redemption value of Class A ordinary shares subject to possible redemption |
306,850 | |||
Class A ordinary shares subject to possible redemption as of June 30, 2022 |
304,806,850 | |||
Increase in redemption value of Class A ordinary shares subject to possible redemption |
1,448,249 | |||
Class A ordinary shares subject to possible redemption as of September 30, 2022 |
$ |
306,255,099 |
||
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
Description |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||
Assets: |
||||||||||||
Investments held in Trust Account-U.S. Treasury Securities (1) |
$ | 306,353,660 | $ | — | $ | — |
(1) |
Excludes $1,439 of cash balance held within the Trust Account |
Table of Contents
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
References in this report (the “Quarterly Report”) to “we”, “us”, “our” or the “Company” are to 10X Capital Venture Acquisition Corp. III, except where the context requires otherwise. References to our “management” or our “management team” refer to our officers and directors. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with our unaudited condensed financial statements and related notes thereto included elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 31, 2022. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
10X Capital Venture Acquisition Corp. III (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on February 10, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). The Company has not selected any specific Business Combination target and the Company has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any Business Combination target with respect to the initial Business Combination with the Company.
Our sponsor is 10X Capital SPAC Sponsor III LLC, a Cayman Islands limited liability company (the “Sponsor”). The registration statement for our initial public offering (the “Initial Public Offering”) was declared effective on January 11, 2022. On January 14, 2022, we consummated our Initial Public Offering of 30,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including the issuance of 3,900,000 Units as a result of the underwriter’s partial exercise of its over-allotment option, at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $20.2 million, of which approximately $14.3 million was for deferred underwriting commissions (Note 6).
Simultaneously with the closing of the Initial Public Offering, we consummated the private placement (“Private Placement”) of 1,153,000 units (each, a “Private Placement Unit” and collectively, the “Private Placement Units”) at a price of $10.00 per Private Placement Unit to the Sponsor and Cantor Fitzgerald & Co. (“Cantor”), generating proceeds of approximately $11.5 million (Note 4).
18
Table of Contents
Upon the closing of the Initial Public Offering and the Private Placement, $304.5 million ($10.15 per Unit) of net proceeds, including the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement, was placed in a trust account (the “Trust Account”) and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended (the “Investment Company Act”), which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to us to pay its taxes, the proceeds from the Initial Public Offering and the sale of the Private Placement Units will not be released from the Trust Account until the earliest of (i) the completion of the initial Business Combination, (ii) the redemption of the Public Shares if we are unable to complete the initial Business Combination within 12 months from the closing of the Initial Public Offering, or January 14, 2023 (the “Combination Period”), subject to applicable law, and (iii) the redemption of the Public Shares properly submitted in connection with a shareholder vote to amend our amended and restated memorandum and articles of association to modify the substance or timing of its obligation to redeem 100% of the Public Shares if we have not consummated the initial Business Combination within the Combination Period or with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of our creditors, if any, which could have priority over the claims of the Public Shareholders (as defined below).
Our management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the Private Placement Units, although substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination (less deferred underwriting commissions). Our Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the net balance in the Trust Account (excluding the amount of deferred underwriting discounts held and taxes payable on the income earned on the Trust Account) at the time of the signing an agreement to enter into a Business Combination. However, we will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that we will be able to successfully effect a Business Combination.
Liquidity and Going Concern
As of September 30, 2022, we had approximately $128,000 outside of the Trust Account and a working capital deficit of approximately $153,000.
Our liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover for certain expenses on our behalf in exchange for issuance of Founder Shares (as defined in Note 5), and loan proceeds from the Sponsor of approximately $137,000 under the Note (as defined in Note 5). We fully repaid the Note on January 14, 2022. Subsequent to the consummation of the Initial Public Offering, our liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account.
In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, members of our founding team or any of their affiliates may provide us with Working Capital Loans (as defined below) as may be required (of which up to $1.5 million may be converted at the lender’s option into private placement-equivalent units at a price of $10.00 per unit).
Based upon the analysis above, our management has determined that we do not have sufficient liquidity to meet its anticipated obligations for at least twelve months after the financial statements are available to be issued, as such, the events and circumstances raise substantial doubt about our ability to continue as a going concern.
In connection with our assessment of going concern considerations in accordance with the ASC 205-40, We have until January 14, 2023 to consummate a Business Combination. It is uncertain that we will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution. Our management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about our ability to continue as a going concern. We intend to complete a Business Combination before the mandatory liquidation date.
19
Table of Contents
We continue to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on our financial position, results of operations and/or our search for a target company, the specific impact is not readily determinable as of the date of these financial statement. The unaudited condensed financial statements does not include any adjustments that might result from the outcome of this uncertainty.
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these unaudited condensed financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements.
Results of Operations
Our entire activity from inception to September 30, 2022 related to our formation, the preparation for the Initial Public Offering, and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. We will not generate any operating revenues until after the completion of our initial Business Combination. We generate non-operating income in the form of investment income from the Trust Account. We will continue to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses. Additionally, we recognize non-cash gains and losses within other income (expense) related to changes in recurring fair value measurement of our derivative liabilities at each reporting period.
For the three months ended September 30, 2022, we incurred net income of approximately $1.1 million, which consisted of approximately $1.4 million in income from investments held in Trust Account, partially offset by approximately $224,000 in general and administrative expense and approximately $113,000 in administrative expenses-related party.
For the three months ended September 30, 2021, we had a net loss of approximately $13,000, consisted solely of general and administrative expenses.
For the nine months ended September 30, 2022, we incurred net income of approximately $652,000, which consisted of approximately $1.9 million in income from investments held in Trust Account, partially offset by approximately $866,000 in general and administrative expense and approximately $338,000 in administrative expenses-related party.
For the period from February 10, 2021 (inception) through September 30, 2021, we had a net loss of approximately $24,000, consisted solely of general and administrative expenses.
Contractual Obligations
Promissory Note—Related Party
The Sponsor agreed to loan us up to $300,000 pursuant to a promissory note, dated on February 18, 2021 and was later amended on December 31, 2021, (the “Note”), to be used for a portion of the expenses of the Initial Public Offering. The Note was non-interest bearing, unsecured and due upon the closing of the Initial Public Offering. The Company borrowed approximately $135,000 under the Note as of December 31, 2021, and fully repaid the Note balance on January 14, 2022.
Working Capital Loan
In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required (the “Working Capital Loans”). If we complete the initial Business Combination, we would repay the Working Capital Loans. In the event that the initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of the Working Capital Loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit at the option of the lender. The units would be identical to the Private Placement Units. As of September 30, 2022 and December 31, 2021, no such Working Capital Loans were outstanding.
20
Table of Contents
Registration and Shareholder Rights
The holders of the Founder Shares, Private Placement Units, private placement shares and private placement warrants and the Class A ordinary shares underlying such private placement warrants and Private Placement Units that may be issued upon conversion of the Working Capital Loans will have registration rights to require us to register a sale of any of our securities held by them pursuant to a registration rights agreement signed upon the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. Notwithstanding the foregoing, Cantor may not exercise its demand and “piggyback” registration rights after five (5) and seven (7) years, respectively, after the effective date of the registration statement and may not exercise its demand rights on more than one occasion. We will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
We granted the underwriter a 45-day option from the date of the Initial Public Offering to purchase up to an additional 3,915,000 Units to cover over-allotments, if any at the Initial Public Offering price less the underwriting discounts and commissions. On January 14, 2022, the underwriter partially exercised the over-allotment option to purchase additional 3,900,000 Units.
The underwriter was entitled to a cash underwriting discount of approximately $5.2 million in the aggregate paid upon the closing of the Initial Public Offering. An additional fee of approximately $14.3 million in the aggregate will be payable to the underwriter for deferred underwriting commission. The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in the event that we complete an initial Business Combination, subject to the terms of the underwriting agreement for the Initial Public Offering.
Critical Accounting Policies and Estimates
The preparation of unaudited condensed financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and the reported amounts of income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following as our critical accounting policies:
Offering Costs Associated with the Initial Public Offering
The Company complies with the requirements of FASB ASC 340-10-S99-1. Offering costs consisted of legal, accounting, and other costs incurred that were directly related to the Initial Public Offering. Offering costs associated with warrants were charged to shareholders’ equity upon the completion of the Initial Public Offering. Offering costs associated with the Class A ordinary shares were charged against the carrying value of Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering.
Net Income (Loss) per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of ordinary shares outstanding for the respective period.
21
Table of Contents
The calculation of diluted net income (loss) per ordinary shares does not consider the effect of the Public Warrants, the Private Placement Warrants and the Rights to purchase an aggregate of 15,576,500 Class A ordinary shares since their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2022, the three months ended September 30, 2021 and for the period from February 10, 2021 (inception) through September 30, 2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
Recent Accounting Pronouncements
In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”. The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the condensed financial statements.
Our management does not believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying unaudited condensed financial statements.
Off-Balance Sheet Arrangements; Commitments and Contractual Obligations
As of September 30, 2022 and December 31, 2021, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments or contractual obligations.
JOBS Act
On April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” under the JOBS Act and are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We elected to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our unaudited condensed financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.
As an “emerging growth company”, we are not required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis), and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our initial public offering or until we are no longer an “emerging growth company,” whichever is earlier.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
22
Table of Contents
Item 4. Controls and Procedures
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.
Evaluation of Disclosure Controls and Procedures
As of September 30, 2022, as required by Rules 13a-15 and 15d-15 under the Exchange Act, our principal executive officer and principal financial and accounting officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II-OTHER INFORMATION
Item 1. Legal Proceedings.
None.
Item 1A. Risk Factors.
There are certain risks and uncertainties in our business that could cause our actual results to differ materially from those anticipated. A detailed discussion of our risk factors was included in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 31, 2022. These risk factors should be read carefully in connection with evaluating our business and in connection with the forward-looking statements and other information contained in this Quarterly Report. Any of the risks described in the Annual Report on Form 10-K for the year ended December 31, 2021, could materially affect our business, financial condition or future results and the actual outcome of matters as to which forward-looking statements are made. There have been no material changes to the risk factors set forth in the Annual Report on Form 10-K for the year ended December 31, 2021 except for the following:
If we are deemed to be an investment company for purposes of the Investment Company Act, we may be forced to abandon our efforts to complete an initial business combination and instead be required to liquidate the Company. To mitigate the risk of that result, on or prior to the 24-month anniversary of the effective date of the registration statement relating to our IPO, we may instruct Continental Stock Transfer & Trust Company to liquidate the securities held in the trust account and instead hold all funds in the trust account in cash. As a result, following such change, we will likely receive minimal, if any, interest, on the funds held in the trust account, which would reduce the dollar amount that our public shareholders would have otherwise received upon any redemption or liquidation of the Company if the assets in the trust account had remained in U.S. government securities or money market funds.
On March 30, 2022, the SEC issued proposed rules (the “SPAC Rule Proposals”), relating, among other things, to circumstances in which SPACs such as us could potentially be subject to the Investment Company Act and the regulations thereunder. The SPAC Rule Proposals would provide a safe harbor for such companies from the definition of “investment company” under Section 3(a)(1)(A) of the Investment Company Act, provided that a SPAC satisfies certain criteria. To comply with the duration limitation of the proposed safe harbor, a SPAC would have a limited time period to announce and complete a de-SPAC transaction. Specifically, to comply with the safe harbor, the SPAC Rule Proposals would require a company to file a report on Form 8-K announcing that it has entered into an agreement with a target company for an initial business combination no later than 18 months after the effective date of the registration statement for its initial public offering. The company would then be required to complete its initial business combination no later than 24 months after the effective date of the registration statement for its initial public offering. We understand that the SEC has recently been taking informal positions regarding the Investment Company Act consistent with the SPAC Rule Proposals.
There is currently uncertainty concerning the applicability of the Investment Company Act to a SPAC, including a company like ours, that does not complete its initial business combination within the proposed time frame set forth in the proposed safe harbor rule. As indicated above, we completed our IPO in January 2022 and have operated as a blank check company searching for a target business with which to consummate an initial business combination since such time (or approximately nine months after the effective date of our IPO, as of the date of this Quarterly Report). If we were deemed to be an investment company for purposes of the Investment Company Act, we might be forced to abandon our efforts to complete an initial business combination and instead be required to liquidate the Company. If we are required to liquidate the Company, our investors would not be able to realize the benefits of owning shares in a successor operating business, including the potential appreciation in the value of our shares and warrants following such a transaction, and our warrants would expire worthless.
The funds in the trust account have, since our IPO, been held only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act. As of September 30, 2022, amounts held in trust account included approximately $1,855,099 of accrued interest. To mitigate the risk of us being deemed to have been operating as an unregistered investment company under the Investment Company Act, we may, on or prior to the 24-month anniversary of the effective date of the registration statement relating to our IPO, or January 14, 2024, instruct Continental Stock Transfer & Trust Company, the trustee with respect to the trust account, to liquidate the U.S. government treasury obligations or money market funds held in the trust account and thereafter to hold all funds in the trust account in cash (i.e., in one or more bank accounts) until the earlier of the consummation of a business combination or our liquidation. Following such liquidation of the assets in our trust account, we will likely receive minimal interest, if any, on the funds held in the trust account, which would reduce the dollar amount our public shareholders would have otherwise received upon any redemption or liquidation of the Company if the assets in the trust account had remained in U.S. government securities or money market funds. This means that the amount available for redemption will not increase in the future.
In addition, even prior to the 24-month anniversary of the effective date of the registration statement relating to our IPO, we may be deemed to be an investment company. The longer that the funds in the trust account are held in short-term U.S. government securities or in money market funds invested exclusively in such securities, even prior to the 24-month anniversary, there is a greater risk that we may be considered an unregistered investment company, in which case we may be required to liquidate. Accordingly, we may determine, in our discretion, to liquidate the securities held in the trust account at any time, even prior to the 24-month anniversary, and instead hold all funds in the trust account in cash, which would further reduce the dollar amount our public shareholders would receive upon any redemption or our liquidation.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
None.
23
Table of Contents
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not Applicable.
Item 5. Other Information.
None.
Item 6. Exhibits.
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
* | Filed herewith. |
** | Furnished. |
24
Table of Contents
SIGNATURES
In accordance with the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
10X CAPITAL VENTURE ACQUISITION CORP. III | ||||
Date: November 14, 2022 | By: | /s/ Hans Thomas | ||
Name: | Hans Thomas | |||
Title: | Chief Executive Officer | |||
(Principal Executive Officer) | ||||
Date: November 14, 2022 | By: | /s/ Guhan Kandasamy | ||
Name: | Guhan Kandasamy | |||
Title: | Chief Financial Officer | |||
(Principal Financial and Accounting | ||||
Officer and Duly Authorized Officer) |
25